Beth Hecht, See Remarks at XERIS PHARMACEUTICALS INC (XERS), bought 4,000 shares at $4.15 ($17K) on 2020-02-14, disclosed to the SEC on 2020-02-18.
Open-market purchase of $17k XERS by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| XERS | SELL | 2026-07-02 | $134K | — | Filing → |
| XERS | SELL | 2026-06-02 | $101K | — | Filing → |
| XERS | SELL | 2026-05-01 | $104K | — | Filing → |